Diversigen Inc. Selected by Nom Nom™ as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Se...
May 22 2020 - 6:00AM
Diversigen, Inc., a subsidiary of OraSure Technologies Inc.
(NASDAQ: OSUR), and Nom Nom™, a direct-to-consumer pet health
brand, today announced that Nom Nom has selected Diversigen as
their preferred provider for metagenomics and microbiome sequencing
and analysis services. Diversigen will also serve as Nom Nom’s
central lab for the generation of high quality microbiome data.
Nom Nom is dedicated to research and data analysis to enable
continued improvement of the health of all pets. The company has
published multiple peer-reviewed studies on the pet microbiome
(“gut health”) including one of the largest pet microbiome studies
to date in which scientists analyzed and characterized the bacteria
living in the guts of 238 pets in an effort to better understand
how these microbes affect pet health. Ongoing efforts are aimed at
evaluating the intersection of nutrition, microbiome, and common
clinical conditions such as allergic diseases and obesity in
pets.
“The personalization of diet and synbiotic recommendations for
pets is the next frontier in companion animal nutrition, and the
microbiome should provide insights on individualized responses to
diet and a possible opportunity to influence and monitor pet
health. This collaboration accelerates advancement of the science
of the pet microbiome,” said Justin Shmalberg DVM, DACVN, DACVSMR,
a board-certified veterinary nutritionist™ and Chief Nutrition
Officer of Nom Nom.
The selection of Diversigen will allow Nom Nom to take advantage
of Diversigen’s science-driven high quality CLIA customized
solutions for metagenomics sequencing, bioinformatics, and
statistical analysis for the study of the microbiome. Diversigen
has a strong track record of supporting microbiome-focused clinical
trials for big pharma customers, as well as thought-leading
microbiome-focused biotech companies. In addition, Diversigen
offers unparalleled scientific bench strength to define and meet
the evolving microbiome arena with experts representing over a
century of microbiome experience, over 300 scientific publications
with more than 100,000 citations.
“The cutting-edge shotgun metagenomic sequencing solutions that
Diversigen has developed provide us with amazing resolution to
advance pet health and increase our understanding of the role that
the microbiome plays in a wide variety of health concerns,” said
Ryan Honaker, PhD, Director of Microbiology at Nom Nom.
“The microbiome field is enormously complex,” said Joy Nassif,
Vice-President, Services at Diversigen Inc. “It is critical to have
strong, scientifically-validated methods to understand the dynamics
of the microbiome. With the use of Diversigen’s science-driven
solutions for metagenomics sequencing and analysis, we’ve seen
first-hand how to rapidly advance our understanding of the
microbiome of pets. Nom Nom is one of the leading
direct-to-consumer pet health brands, and we are excited to work
with them to help understand the microbes living in the guts of
pets and how microbes affect pet health.”
About Diversigen Inc.Diversigen, Inc. is a
subsidiary of OraSure Technologies Inc. Diversigen and CoreBiome
came together to create one company that is powering microbiome
discovery through sequencing, analysis, and
consulting services geared toward the study of the microbiome of
living organisms and environments. Diversigen provides consultative
end-to-end solutions for sequencing, bioinformatics, and
statistical analysis for the study of the microbiome of living
organisms and environments. Diversigen, Inc. operates a
state-of-the-art CLIA accredited laboratory deploying a variety of
techniques to extract high quality nucleic acids from a multitude
of sample types for subsequent metagenomics analysis. Diversigen’s
flexible sequencing and computing capacity, combined with ongoing
improvements in analytic tools and their applications, allows for
customized project-specific strategies. For more information, visit
www.diversigen.com or contact info@diversigen.com.
About OraSure Technologies
OraSure Technologies empowers the global community
to improve health and wellness by providing access to accurate,
essential information. Together with its wholly owned subsidiaries,
DNA Genotek, Diversigen, Core Biome (now operating under the
Diversigen brand) and Novosanis, OraSure provides its customers
with end-to-end solutions that encompass tools, services and
diagnostics. The OraSure family of companies is a leader in the
development, manufacture, and distribution of rapid diagnostic
tests, sample collection and stabilization devices, and molecular
services solutions designed to discover and detect critical medical
conditions. OraSure’s portfolio of products is sold globally to
clinical laboratories, hospitals, physician’s offices, clinics,
public health and community-based organizations, research
institutions, government agencies, pharma, commercial entities and
direct to consumers.
For more information on OraSure Technologies,
please visit www.orasure.com.
About Nom Nom™Currently delivering over a
million pre-portioned meals to dog- and cat- friendly homes each
month, Nom Nom is more than a pet food company. Founded in the SF
Bay Area in 2015, the brand employs a board certified veterinary
nutritionist and doctor of veterinary medicine, six science and
R&D specialists (with PhDs, no less) and over 175 passionate
pet lovers from CA to TN. They home-deliver meals for dogs and cats
made with the freshest, highest-quality ingredients, prepared
weekly in the company's own kitchen facilities, tailored to meet
the specific nutrition needs of each pet. But Nom Nom is more than
just a pet food company. Nom Nom is a pet health pioneer poised to
disrupt the pet health industry backed by science and research into
the microbiome of dogs and cats. For more information, visit
www.nomnomnow.com or contact press@nomnomnow.com.
Investor Contact: Sam MartinArgot
Partners212-600-1902orasure@argotpartners.com |
Media Contact: Jeanne MellVP Corporate
Communications484-353-1575media@orasure.com |
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024